会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • USE OF ESTRADIOL VALERATE COMBINED WITH DIENOGEST FOR ORAL THERAPY OF DYSFUNCTIONAL UTERINE BLEEDING IN THE FORM OF ORAL CONTRACEPTIVES
    • 戊酸雌二醇联合使用诺孕素子宫出血的DYSF UNKTIONELLEN单元口服避孕药口服治疗
    • WO2007042111A3
    • 2007-10-11
    • PCT/EP2006008626
    • 2006-09-05
    • SCHERING AGZEUN SUSANBOUDES POLENDRIKAT JANSECCI ANGELOZIMMERMANN HOLGER
    • ZEUN SUSANBOUDES POLENDRIKAT JANSECCI ANGELOZIMMERMANN HOLGER
    • A61K31/565A61K31/57A61P15/00A61P15/18
    • A61K31/565A61K31/57
    • The invention relates to the use of estradiol valerate combined with 17a- cyanomethyl-17-ß-hydroxyestra-4,9-diene-3on (dienogest) for producing a multi-phase combination preparation for the oral therapy of the dysfunctional uterine bleeding in the form of oral contraceptives. Said combination of estradiol valerate with dienogest comprises a first phase consisting of 2 daily dose units of estradiol valerate at 3 mg, a second phase consisting of 2 groups of daily dose units, whereby the first group contains 5 daily dose units of a combination of 2 mg estradiol valerate and 2 mg of dienogest and the second group contains 17 daily dose units consisting of a combination of 2 mg of estradiol valerate and 3 mg dienogest, a third phase consisting of 2 daily dose units having 1 mg estradiol valerate and an additional phase consisting of 2 daily dose units on a pharmaceutically harmless placebo. All of the daily dose units of the multi-phase combination and the pharmaceutically harmless placebo correspond to 28 days. The duration of application comprises at least one menstruation cycle and is dependent on individual wishes of the woman with respect to contraception.
    • 使用戊酸雌二醇与17A-氰甲基-17-SS-hydroxyestra -4,9-二烯-3-酮(地诺孕素),用于产生用于功能性子宫出血在单元出血与口服避孕的口服治疗的多相组合制剂实现相结合。 戊酸雌二醇与地诺孕素在这种情况下,组合包含的戊酸雌二醇的2日剂量单元的第一阶段在3毫克,2组的每日剂量单位,的第二阶段,其中,所述第一组2毫克戊酸雌二醇的组合的5日剂量单位和2mg的地诺孕素和第二组17 含有2毫克戊酸雌二醇和3mg地诺孕素,2日剂量单位含有1mg戊酸雌二醇和另一相由药学上可接受的地方 - 博的2日剂量单元的第三阶段的组合的每日剂量单位。 多相组合及其药学上无害的安慰剂的整个日剂量单元对应于28天。 治疗的持续时间包括至少一个管理周期,并依赖于妇女的个人欲望避孕。
    • 9. 发明申请
    • METHOD FOR REPRODUCING DATA WHICH IS STORED ON A STORAGE MEDIUM TEN
    • 方法上播放存储在存储介质
    • WO0133567A3
    • 2001-12-20
    • PCT/DE0003789
    • 2000-10-27
    • BOSCH GMBH ROBERTBECKER VOLKERZIMMERMANN HOLGERBAAS DIETER
    • BECKER VOLKERZIMMERMANN HOLGERBAAS DIETER
    • H04N5/85G11B17/22G11B19/02G11B20/10G11B27/00G11B27/10G11B27/36
    • G11B17/228G11B19/02G11B20/10527G11B27/002G11B2020/10768G11B2220/213G11B2220/2545G11B2220/2562
    • The invention relates to a method for reproducing data, especially digital audio and/or video data, which is stored on a storage medium (1, 5, 10), especially an optical storage plate, in a playback device (15). Accelerated selection of storage mediums that have to be reproduced or ejected from the playback device (15) is possible. In a first operating mode, data is stored in a, preferably non-volatile, memory (20) during playback of the storage medium (1, 5, 10). In a second operating mode, the storage medium (1, 5, 10) is selected, especially for playback and reproduction. At least a portion of the data which is stored in the memory (20) is replayed and reproduced within a period of time, wherein the selected storage medium (1, 5, 10) is brought into a playback position, wherein the data stored on the storage medium (1, 5, 10) can be read out by a reading device, or into an ejection position, wherein the selected storage medium (1, 5, 10) can be taken out, by means of a reserve memory (25).
    • 我们将描述一种用于在重放装置(15),其中,加速选择再现上的存储介质(1,5,10),特别是在光学存储盘的存储数据,特别是数字音频和/或视频数据的方法 从或到从播放器再现auszuschiebenden(15)的存储介质是可能的。 在第一种操作模式中,存储在一个优选的非易失性存储器(20)中的存储介质(1,5,10)的再现期间的数据。 在操作的第二模式中的存储介质(1,5,10),特别是用于播放和再现操作所选择。 内的期间中,从在其中存储介质(1,5,10)所存储的数据可通过读取装置读取,或在在播放位置上的存储存储器(25)所选择的存储介质(1,5,10) 排出位置,从所选择的存储介质(1,5,10)是可拆卸的,被带,至少所述存储器(20)的一部分被回放存储和再现数据。